"The NG Biotech rapid test is CE Marked for professional use for COVID-19 testing in Europe."
From the ASX announcement on April 15 headed
"Atomo receives additional order for COVID-19 testdevicesCOVID-19 test devices ordered to date:947,200"
So the NG Biotech test is available for use in Europe.
Number of cases in Europe = 1,168,284
Number of people in Europe = 741,000,000
Seems like a good opportunity to me for sales in Europe alone.
50% margin ? The product, page-52
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
